Investment Trusts

Syncona Limited

SYNC:LSE

Syncona Limited

  • Price (GBX)120.40
  • Today's Change-1.60 / -1.31%
  • Shares traded440.31k
  • 1 Year change-21.10%
  • Beta0.3243
Data delayed at least 20 minutes, as of May 03 2024 16:37 BST.
More ▼

Profile data is unavailable for this security.

About the company

Syncona Limited is a Guernsey-based closed-ended investment company. The Company’s investment objective is to achieve superior long-term capital appreciation from its investments. It seeks to achieve returns over the long term. It focuses on creating, building and scaling companies around science to create a diversified portfolio of 20-25 global healthcare businesses, across development stage and therapeutic areas. It focuses on developing treatments for patients by working in close partnership with academic founders and management teams. The Company makes its life science investments through Syncona Holdings Limited, a subsidiary of the Company. It maintains its capital pool through Syncona Investments LP Incorporated (the Partnership) in which the Company is the sole limited partner. The general partner of the Partnership is Syncona GP Limited (the General Partner), a wholly owned subsidiary of the Company. Syncona Investment Management Limited is its alternative investment manager.

  • Revenue in GBP (TTM)-144.46m
  • Net income in GBP-165.38m
  • Incorporated2012
  • Employees0.00
More ▼

Profile

Management group(s)Syncona Investment Management Limited
AIC sectorBiotechnology & Healthcare
ISINGG00B8P59C08
Launch date26 Oct 2012
Share typeOrdinary Share
StructureInvestment Trust
Base currencyGBP

Objective

To achieve superior long-term capital appreciation from its investments. The Company invests in life science businesses and single or multi-asset projects. The Company will target an IRR per share across its investment portfolio of 15% p.a. over the long term. Over time, it is intended that the Company should invest the significant majority of its assets in Life Science Investments.

Managed by

Chris Hollowood

Management & contract fees

The company will pay SIML an annual fee of up to 1.05% p.a. of the NAV of company. The fee will be payable monthly in arrears and each payment shall be calculated using the monthly NAV as at the relevant month end.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		SYNC:LSE since
announced		Transaction
value
Freeline Therapeutics Holdings PLCDeal completed22 Nov 202322 Nov 2023Deal completed1.18%28.30m
Data delayed at least 20 minutes, as of May 03 2024 16:37 BST.

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
European Smaller Companies Trust PLC91.68m78.68m704.91m0.00704.91m0.00
Apax Global Alpha Ltd60.01m45.86m733.23m0.00733.23m0.00
VinaCapital Vietnam Opportunity Fund Ltd160.12m127.51m734.64m0.00734.64m0.00
Temple Bar Investment Trust PLC95.11m86.83m749.24m0.00749.24m0.00
TwentyFour Income Fund Ltd129.47m121.12m765.78m0.00765.78m0.00
JPMorgan Japanese Investment Trust PLC61.35m52.82m765.93m0.00765.93m0.00
Schiehallion Fund Ltd62.21m54.04m766.41m0.00766.41m0.00
Schroder AsiaPacific Fund plc34.21m21.90m777.66m0.00777.66m0.00
Syncona Ltd-144.46m-165.38m785.75m0.00785.75m0.00
Global Smaller Companies Trust PLC-20.41m-28.39m800.10m0.00800.10m0.00
ICG Enterprise Trust PLC71.43m45.56m803.32m0.00803.32m0.00
NB Private Equity Partners Ltd52.17m21.58m814.15m--814.15m--
Oakley Capital Investments Ltd57.09m47.49m838.87m0.00838.87m0.00
Merchants Trust plc-19.61m-30.25m843.97m0.00843.97m0.00
Biopharma Credit PLC108.18m86.44m856.12m11.00856.12m11.00
Patria Private Equity Trust PLC80.15m60.96m878.61m0.00878.61m0.00
Data as of May 03 2024. Currency figures normalised to Syncona Limited's reporting currency: UK Pound GBX

Institutional shareholders

54.50%Per cent of shares held by top holders
HolderShares% Held
The Wellcome Trust Ltd. (Investment Management)as of 31 Mar 2023186.00m28.37%
BlackRock Investment Management (UK) Ltd.as of 12 May 202368.19m10.40%
Schroder & Co. Ltd.as of 31 Mar 202333.49m5.11%
Matthews International Capital Management LLCas of 31 Dec 202314.34m2.19%
Liontrust Investment Partners LLPas of 29 Mar 202411.31m1.73%
Columbia Threadneedle Asset Managers Ltd.as of 29 Feb 202410.18m1.55%
Columbia Threadneedle Management Ltd.as of 29 Mar 202410.11m1.54%
Schroder Investment Management Ltd.as of 31 Jan 20249.79m1.49%
T. Rowe Price International Ltd.as of 31 Mar 20248.43m1.29%
Vanguard Global Advisers LLCas of 31 Mar 20245.46m0.83%
More ▼
Data from 31 Dec 2023 - 30 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.